AI Tool for Matching Cancer Patients to Trials
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
- Sex
- Any
- Study type
- Observational
- Participants needed
- 50,000 (estimated)
- Sponsor
- Massive Bio, Inc. · Industry
This trial is looking for cancer patients to see if an AI tool can help match them to clinical trials. Patients will have their cancer-related biomarkers evaluated to find suitable studies for their condition.
You may be able to join if
- I have been diagnosed with cancer.
- I have solid or blood cancers.
- I have cancer-related biomarkers like PD-L1 or BRCA.
- My doctor is considering pre-screening for clinical trials.
You may not be able to join if
- My ECOG performance status is greater than 2.
- I have abnormal organ function.
- I am enrolled in hospice care.
Summarized in plain language from this trial's official eligibility criteria. The full criteria are further down this page — only the research team can confirm whether you qualify.
Think this trial could be right for you?
Answer three quick questions written from this study's own rules to see if you may qualify. No account needed to find out.
Check Your EligibilityInternational registry for cancer patients evaluating the feasibility and clinical utility of an Artificial Intelligence-based precision oncology clinical trial matching tool, powered by a virtual tumor boards (VTB) program, and its clinical impact on pts with advanced cancer to facilitate clinical trial enrollment (CTE), as well as the financial impact, and potential outcomes of the intervention.
Loading trial locations…